The White House said Tuesday that "the ball is in China's court," as far as a trade deal with the U.S. is concerned.

China has launched a sweeping and strategic retaliation against the US in response to long-standing Trump-era tariffs, with measures ranging from harsh new tariffs on US goods to targeted strikes ...

The White House said Tuesday that "the ball is in China's court," as far as a trade deal with the U.S. is concerned.

BofA lowered the firm’s price target on Illumina (ILMN) to $75 from $90 and keeps an Underperform rating on the shares. Sentiment for Life ...

Inflation regularly topped 4% yearly until the mid-1990s, when freer trade and globalization began to intensify.

Beijing’s strategy to hit back at President Trump goes well beyond tariffs, targeting companies who bank on their China ties.

Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. | Looking to ...

Biotechnology company Illumina has appointed Julie Hiner as head of communications. Hiner reports to Illumina CEO Jacob Thaysen and she was appointed to the role in January. Neither Hiner nor an ...

RBC Capital analyst Conor McNamara lowered the firm’s price target on Illumina (ILMN) to $112 from $128 and keeps an Outperform rating on the ...

The investigation indicates that China will likely favor local medtech companies over foreign competition amid international ...

China responded to President Trump’s trade war with increased tariffs and economic restrictions on certain U.S. firms ...

American clothing company PVH, which owns Calvin Klein, as well as biotechnology company Illumina were added to Beijing's ...